Evidence map›Paper›PMID 42418445›Full record

ArticleArchives of insect biochemistry and physiology2026

Behavioral Resistance in Varroa destructor: First Evidence in Response to Acaricide?

Théa Missud, Max Watkins, Paulo Damian Mielgo, Alexandros Papachristoforou, Karine Monceau, Benjamin Poirot

Abstract read
In one paragraph

Article in Archives of insect biochemistry and physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Théa MissudCentre d'Etudes Biologiques de Chizé, UMR-CNRS 7372, La Rochelle Université, Villiers-en-Bois, France.ORCID https://orcid.org/0009-0003-0524-9999
Max WatkinsVita (Europe) Limited, Vita House, Basingstoke, UK.
Paulo Damian MielgoVita (Europe) Limited, Vita House, Basingstoke, UK.
Alexandros PapachristoforouLaboratory of Applied Apiculture, Department of Animal Science, University of Thessaly, Larissa, Greece.
Karine MonceauCentre d'Etudes Biologiques de Chizé, UMR-CNRS 7372, La Rochelle Université, Villiers-en-Bois, France.
Benjamin PoirotApinov, Scientific Beekeeping and Training Center, Lagord, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ectoparasite Varroa destructor (Mesostigmata: Varroidae) poses a major threat to honey bee colonies due to its role as a viral vector and its capacity to develop resistance to treatments. While physiological resistance and target-site mutations are well documented, behavioral mechanisms remain largely unexplored. This study investigated the potential existence of behavioral resistance in V. destructor, defined as a modification of behavior in response to an acaricidal molecule. Using Y-maze olfactometric assays, we evaluated mite responses to three acaricides-amitraz, tau-fluvalinate, and oxalic acid-across five French populations with distinct treatment histories. Forty groups of five mites were exposed to "acaricide/solvent" pairs, and choices were recorded after 18 h. Results revealed marked heterogeneity among populations. Two population exhibited significant avoidance of tau-fluvalinate, providing the first case of avoidance behavior in V. destructor, but no coinciding phenotypic resistance. No avoidance was detected for amitraz and oxalic acid. These findings suggest that behavioral resistance may exists in France but is not systematic. Identifying this phenomenon opens new perspectives on the parasite's adaptation to treatments and underscores the need to integrate behavioral aspects into control strategies.

Indexed as

AcaricidesVarroidaeAnimalsBeesBehavior, AnimalDrug ResistanceFranceNitrilesOxalic AcidPyrethrinsToluidinesAcaricidesamitrazfluvalinateNitrilesOxalic AcidPyrethrinsToluidinesavoidance behaviorhoney beemitespesticidepest managementY‐maze

Identifiers

PMID42418445
PMCPMC13345143

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.